American journal of respiratory and critical care medicine
-
Am. J. Respir. Crit. Care Med. · Oct 2017
Editorial Historical ArticleFifty Years of Physiology in Obstructive Sleep Apnea.
-
Am. J. Respir. Crit. Care Med. · Oct 2017
ReviewHealth Disparities in Patients with Pulmonary Arterial Hypertension: A Blueprint for Action. An Official American Thoracic Society Statement.
Health disparities have a major impact in the quality of life and clinical care received by minorities in the United States. Pulmonary arterial hypertension (PAH) is a rare cardiopulmonary disorder that affects children and adults and that, if untreated, results in premature death. The impact of health disparities in the diagnosis, treatment, and clinical outcome of patients with PAH has not been systematically investigated. ⋯ At present, there are few studies that address health disparities in PAH. Given the potential adverse impact of health disparities, we recommend that research efforts be undertaken to address the topics discussed in the document. Awareness of health disparities will likely improve advocacy efforts, public health policy and the quality of care of vulnerable populations with PAH.
-
Am. J. Respir. Crit. Care Med. · Oct 2017
Comparative StudyComparing Drivers and Dynamics of Tuberculosis (TB) in California, Florida, New York and Texas.
There is substantial state-to-state heterogeneity in tuberculosis (TB) in the United States; better understanding this heterogeneity can inform effective response to TB at the state level, the level at which most TB control efforts are coordinated. ⋯ There is substantial state-level heterogeneity in TB epidemiology in the four states, which reflect both demographic factors and potential differences in the natural history of TB. These differences may inform resource allocation decisions in these states.
-
Am. J. Respir. Crit. Care Med. · Oct 2017
A Two Biomarker Model Predicts Mortality in the Critically Ill with Sepsis.
Improving the prospective identification of patients with systemic inflammatory response syndrome (SIRS) and sepsis at low risk for organ dysfunction and death is a major clinical challenge. ⋯ We have developed a simple, robust biomarker-based model that identifies patients with SIRS/sepsis at low risk for death and organ dysfunction.